Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$20.5

Avg closing price
Price range

2 Ken Griffin Cellular Biomedicine Group Trades

Ken Griffin started to build up the position in Cellular Biomedicine Group in Q3 2018. Since then they sold 10.4 Thousand shares. The investor sold all their shares in Q4 2018 and doesn't own any shares in Cellular Biomedicine Group anymore.

Avg closing price
Price range
Sold -10.4 Thousand shares Q4 2018
Avg closing price $16.98
Price range $12.32 - $20.34
New holding (+10.4 Thousand shares) Q3 2018
Avg closing price $20.51
Price range $18.15 - $23.65

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!